calcitonin receptor ; Mus musculus






58 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1615762 Prostaglandin E2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells. J Bone Miner Res 1992 May 6
2 1650619 Calcitonin receptor expression and its regulation by 1 alpha-25-dihydroxyvitamin D3 during de novo osteoclast formation in organ cultures of fetal mouse metatarsals. Bone Miner 1991 Jun 3
3 1851370 Effect of prostaglandins E1, E2, and F2 alpha on osteoclast formation in mouse bone marrow cultures. J Bone Miner Res 1991 Feb 5
4 7664679 Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 1995 Oct 1
5 7863821 Glucocorticoid regulation of calcitonin receptor in mouse osteoclast-like multinucleated cells. J Bone Miner Res 1994 Nov 1
6 8536630 Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism. Endocrinology 1996 Jan 2
7 9002981 Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts. Endocrinology 1997 Feb 6
8 10067826 Calcitonin-dependent down-regulation of the mouse C1a calcitonin receptor in cells of the osteoclast lineage involves a transcriptional mechanism. Endocrinology 1999 Mar 1
9 10423015 Calcitonin receptor antibodies in the identification of osteoclasts. Bone 1999 Jul 1
10 12202955 The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand. Calcif Tissue Int 2002 Nov 3
11 14609735 Three receptor-activity-modifying proteins define calcitonin gene-related peptide or adrenomedullin selectivity of the mouse calcitonin-like receptor in COS-7 cells. Biochem Pharmacol 2003 Dec 1 1
12 15007076 Selective inactivation of adrenomedullin over calcitonin gene-related peptide receptor function by the deletion of amino acids 14-20 of the mouse calcitonin-like receptor. J Biol Chem 2004 May 7 1
13 15194494 Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2. Biochem Biophys Res Commun 2004 Jul 9 5
14 16614077 Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones. Endocrinology 2006 Jul 4
15 17971446 A heat shock protein 90 binding domain in endothelial nitric-oxide synthase influences enzyme function. J Biol Chem 2007 Dec 28 1
16 18627265 Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. J Bone Miner Res 2008 Aug 5
17 19162326 Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties. Mol Immunol 2009 Mar 2
18 20850575 The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorption. Bone 2011 Feb 1
19 21042782 Effect of omeprazole on the expression of transcription factors in osteoclasts and osteoblasts. Int J Mol Med 2010 Dec 1
20 22311731 Cardiac FKBP12.6 overexpression protects against triggered ventricular tachycardia in pressure overloaded mouse hearts. Basic Res Cardiol 2012 Mar 2
21 23519892 Calcitonin: physiology or fantasy? J Bone Miner Res 2013 May 3
22 23832809 The role of cGMP/cGKI signalling and Trpc channels in regulation of vascular tone. Cardiovasc Res 2013 Nov 1 1
23 23931966 Hyperprolactinemia changes the sulfated glycosaminoglycan amount on the murine uterus during the estrous cycle. Fertil Steril 2013 Nov 2
24 23990469 Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling. J Biol Chem 2013 Oct 11 1
25 24196871 Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells. J Bone Miner Metab 2014 Sep 1
26 24368301 A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulation. J Control Release 2014 Feb 10 2
27 24732351 Curcumol suppresses RANKL-induced osteoclast formation by attenuating the JNK signaling pathway. Biochem Biophys Res Commun 2014 May 2 1
28 25486133 The role of calcitonin receptor signalling in polyethylene particle-induced osteolysis. Acta Biomater 2015 Mar 1
29 25998451 Calcium-containing crystals enhance receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways. Rheumatology (Oxford) 2015 Oct 3
30 26440893 Calcitonin Receptor Signaling Inhibits Muscle Stem Cells from Escaping the Quiescent State and the Niche. Cell Rep 2015 Oct 13 4
31 26769009 Effect of time-dependent cryotherapy on redox balance of quadriceps injuries. Cryobiology 2016 Feb 2
32 27858552 Fluvastatin Inhibits Osteoclast Differentiation and Porphyromonas gingivalis Lipopolysaccharide-Induced Alveolar Bone Erosion in Mice. J Periodontol 2017 Apr 1
33 28666011 Differential effects of Calca-derived peptides in male mice with diet-induced obesity. PLoS One 2017 1
34 28713268 Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis<i>In Vivo</i> and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption <i>In Vitro</i>. Front Pharmacol 2017 2
35 29087309 Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission. Proc Natl Acad Sci U S A 2017 Nov 14 2
36 29442051 3',4',7,8-Tetrahydroxyflavone inhibits RANKL-induced osteoclast formation and bone resorption. Pharmazie 2017 Mar 1 2
37 29471321 Overexpression of heparanase in mice promoted megakaryopoiesis. Glycobiology 2018 May 1 1
38 29631057 High affinity sugar ligands of C-type lectin receptor langerin. Biochim Biophys Acta Gen Subj 2018 Jul 3
39 30224373 Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity. Cancer Res 2019 Jan 1 6
40 30366383 Quercitrin Nanocoated Implant Surfaces Reduce Osteoclast Activity In Vitro and In Vivo. Int J Mol Sci 2018 Oct 25 1
41 30761125 The C-type Lectin Receptor-Driven, Th17 Cell-Mediated Severe Pathology in Schistosomiasis: Not All Immune Responses to Helminth Parasites Are Th2 Dominated. Front Immunol 2019 2
42 31323222 Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways. Eur J Pharmacol 2019 Sep 15 1
43 31514188 Protective Effects of Prunasin A against the Differentiation of Osteoclasts and Destruction of Cartilage via the Receptor Activator of Nuclear Factor-Kappa-Β Ligand/Mitogen-Activated Protein Kinase/Osteoprotegerin Pathway in a Rat Model of Arthritis. Pharmacology 2019 1
44 31675485 Glucocorticoids employ the monomeric glucocorticoid receptor to potentiate vitamin D<sub>3</sub> and parathyroid hormone-induced osteoclastogenesis. FASEB J 2019 Dec 2
45 32152204 Amylin/Calcitonin Receptor-Mediated Signaling in POMC Neurons Influences Energy Balance and Locomotor Activity in Chow-Fed Male Mice. Diabetes 2020 Jun 1
46 32188623 Type I IFN, Ly6C<sup>+</sup> cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination. Mol Cancer Ther 2020 Jun 8
47 32292339 Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis <i>Via</i> Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways. Front Pharmacol 2020 1
48 32448982 A TLR4-TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells. Cancer Immunol Immunother 2020 Oct 6
49 33403674 Celecoxib treatment dampens LPS-induced periapical bone resorption in a mouse model. Int Endod J 2021 Aug 3
50 33945918 Aloperine improves osteoporosis in ovariectomized mice by inhibiting RANKL-induced NF-κB, ERK and JNK approaches. Int Immunopharmacol 2021 Aug 1